2294 results about "Lower blood pressure" patented technology

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

A method for the treatment of a patient for the purpose of lowering blood pressure and / or treating cardiac arrhythmias, particularly atrial fibrillation includes the insertion of an ablation catheter into the lumen of a renal artery. The ablation catheter is equipped with an electrode that can stimulate the wall tissue in the renal artery to help identify the location of a renal nerve. High-frequency stimulation of the renal nerve causes a decrease in the blood pressure of the patient thereby indicating that a renal nerve is nearby. The ablation catheter is used to ablate the renal nerve using radiofrequency, ultrasound, microwave energy or cryogenic cooling. An irrigated ablation catheter may be used to decrease damage to cells in the wall of the lumen of the renal artery other than the renal nerve, such as the endothelial cells.

The invention comprises the use of activity-reducing effectors of dipeptidyl peptidase (DP IV) and DP IV-analogous enzyme activity in the blood of a mammal to lower the blood sugar level and the blood pressure in mammalian organisms.

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

This document provides natriuretic polypeptides. For example, this document provides polypeptides having a natriuretic activity. In some cases, a polypeptide provided herein can have natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing natriuretic activities within a mammal.

A method of cufflessly and non-invasively measuring blood pressure in a wrist region of a patient in association with a communication device that relays the information being measured includes: detecting a magnitude difference between a plurality of pulse wave signals detected from a wrist of a user; detecting feature points from an electrocardiogram (ECG) and pulse wave signals detected from the user; extracting variables needed to calculate the highest blood pressure and the lowest blood pressure using the detected feature points; and calculating the highest blood pressure and the lowest blood pressure of the user by deducing a scatter diagram using the extracted variables.

A method for the treatment of a patient for the purpose of lowering blood pressure and / or treating other medical conditions such as cardiac arrhythmias. A catheter having an ablation element is placed inside the body of a patient and is directed to a targeted location either on in the abdominal aorta where the right or left renal arteries branch from the aorta at or near the superior junction or ostia or on the inside of the inferior vena cava near the junction with the right renal vein or in the left renal vein at a position spatially near where the left renal artery branches from the abdominal aorta. Catheters designed for use in the method where these targeted locations are also disclosed and claimed.

Methods and devices for reducing ventricle filling volume are disclosed. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to reduce ventricle filling volume or even blood pressure. When the heart is stimulated in a consistent way to reduce blood pressure, the cardiovascular system may over time adapt to the stimulation and revert back to the higher blood pressure. In some embodiments, the stimulation pattern may be configured to be inconsistent such that the adaptation response of the heart is reduced or even prevented. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to cause at least a portion of an atrial contraction to occur while the atrioventricular valve is closed. Such an atrial contraction may deposit less blood into the corresponding ventricle than when the atrioventricular valve is opened throughout an atrial contraction.

The invention relates to highly concentrated DHA and EPA formulations in a soft gel capsule. A capsule may contain at least 80% omega-3 fatty acids, salts or derivatives thereof, where EPA and DHA are present in relative amounts of greater than or equal to 3:1 or less than or equal to 1:3, and constitute at least 75% to greater than 95% of the total fatty acids present in the capsule. Capsules of the invention may be provided in a blister package so as to provide clean and protected oils that are easy to travel with. Compliance is improved with one-pill-a-day dosing and the days of the week imprinted on the foil packing. Anitoxidant protection may be provided by rosemary and vitamin C. The invention also provides a methods of treatment, modulation or prophalaxis of coronary disease, altering serum LDL-cholesterol and / or HDL-cholesterol, lowering serum triglycerides, lowering blood pressure, pulse rate, altering the activity of the blood coagulation factor VII complex, mild hypertension, protection from cyclosporine toxicity in kidney transplant, rheumatoid arthritis, development and progression of retinopathy, hypertriglyceridemia, and neurological disorders in a subject.

The technology for producing golden flower Qianliang tea (Hua-juan tea) is characterized in that the technology comprises the process steps as follow: plucking criteria-water removing in high temperature-rolling and shaping-pile-fermentation-dry and adding incense-stems picking and sieving-matching and pile-classificaition and weighting-steam softening-moisture detection-adpressing and sizing-premilary test and baking-cultivating golden flower-aerationagitation. The technology is an improved deep processing technology. The processes of the pile-fermentation and the cultivating golden flower ensure that the appearance of the products is ooiu colour, the interior is brown, and even distributed beneficial organism (namely, golden flower)-eurotium cristatum is clearly saw, the shangse is bright red, the taste is pure and aromatic, and the flower is aromatic, and has the health care functions of promoting sleeping, invigorating stomach and promoting digestion, relaxing bowel, slaking thirst and helping produce saliva, antidiabetics, lowering blood pressure, curing bloated, cuing laxness, etc. The technology fully actives microelements such as vitamins contained in tea, mineral composition, 18 amino acid, protein, glucide, folic acid, catchol which are beneficial to human health and easily absorbed, and the cultivation of golden flower has substantial transformation on tea polyphenols, caffeine, and theophylline that are transferred into elements that are beneficial to human health, all ages, expand market, have high cultural value, provide collection opportunity for black tea lovers.

Methods and devices for reducing ventricle filling volume are disclosed. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to reduce ventricle filling volume or even blood pressure. When the heart is stimulated in a consistent way to reduce blood pressure, the cardiovascular system may over time adapt to the stimulation and revert back to the higher blood pressure. In some embodiments, the stimulation pattern may be configured to be inconsistent such that the adaptation response of the heart is reduced or even prevented. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to cause at least a portion of an atrial contraction to occur while the atrioventricular valve is closed. Such an atrial contraction may deposit less blood into the corresponding ventricle than when the atrioventricular valve is opened throughout an atrial contraction.

The invention provides a health-care soybean milk powder and a preparation method thereof, which relates to a health-care drinking product. The health-care soybean milk powder comprises the followingcomponents, by weight percent: 50-90% of soybean milk powder or black bean milk powder or pease milk powder or mung bean milk powder or red bean milk powder, 1-10% of spirulina powder, 1-10% of balsampear powder, 1-30% of hawthorn powder, 1-30% of yam powder, 1-30% of pumpkin powder and 1-30% of buckwheat. In the health-care soybean milk powder and the preparation method thereof, spirulina, balsam pear, hawthorn, yam, pumpkin and buckwheat which are processed are added into soybean milk powder to prepare the health-care soybean milk powder with better effect of lowering blood pressure, fat and blood sugar.

The invention belongs to the technical field of affinal drug and diet formulas and new resource food, and particularly provides blood fat-reducing medical science formula food, specific medical formula food or non-specific medical formula food. The formula food is prepared by performing reasonable compatibility on multiple affinal drug and diet traditional Chinese medicines according to the traditional Chinese medicine essence theory and mixing drug-diet dual purpose traditional Chinese medicine extract essence extracted through a semi-bionic extraction method, multiple microencapsulated probiotics, oligopeptides extracted through biological enzymolysis, prebiotics, amino acid, carbohydrate, fat with a health-care function, multiple vitamins and mineral substances according to the requirements of a 'special medial-purpose formula food general rule' by combining the constitutive characters of hyperlipidemia patients; the formula food not only can serve as a single nutrition source to meet the nutritional requirement of the hyperlipidemia patients, but also achieves the effects of reducing total cholesterol, reducing serum triglyceride, reducing an atherosclerosis index, reducing blood pressure, reducing blood sugar, reducing fat to lose weight and enhancing the immunity.

A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.

The invention relates to an enzymolytic lactoprotein ferrous complex, a microcapsule iron supplement and a preparation method thereof. In the preparation method, ferrous salt is complexed with an enzymolysis product of lactoprotein, which can improve solubility of iron salt under an alkalescent intestinal condition, improves absorptivity and availability of iron and ensures a safe and pollution-free preparation process; a proper coating material is adopted for microencapsulating the enzymolytic lactoprotein ferrous complex to prepare the microcapsule iron supplement agent of the enzymolytic lactoprotein ferrous complex; the iron supplement agent can mask self-odor of the ferrous salt, prevent the ferrous iron from oxidation, gradually release Fe under the alkalescent intestinal condition to ensure high biological absorptivity and biological availability of the Fe, and has no toxic and side effect; and the enzymolytic lactoprotein can prevent and treat iron-deficiency anemia, and has physiological functions of resisting oxidation, adjusting immunity, lowering blood pressure and the like.

Hydrogenated pyrido[4,3-b]indoles, pyrido[3,4-b]indoles and azepino[4,5-b]indoles are described. The compounds may bind to and are adrenergic receptor α2B antagonists. The compounds may also bind to and antagonize adrenergic receptor α2B. The compounds may find use in therapy, e.g., to (i) reduce blood pressure and / or (ii) promote renal blood flow and / or (iii) decrease or inhibit sodium reabsorption. The compounds may also be used to treat diseases or conditions that are, or are expected to be, responsive to a decrease in blood pressure. Use of the compounds to treat cardiovascular and renal disorders is particularly described.

The invention discloses a celery tea drink and a preparation method thereof and belongs to the technical field of food processing. The celery tea drink is prepared from six homologous medicine and food Chinese medicinal herbs of fresh celery, cassia seed, hawthorn, barbary wolfberry fruit, liquorice, chrysanthemum and honey, an acidity regulator, a sweetener, and the like. The celery tea drink has fresh and cool mouthfeel and the effects of clearing heat, promoting blood circulation and removing blood stasis, soothing the liver, promoting urination, lowering blood pressure and blood fat, and the like, is a pure natural healthy functional drink, is suitable for people of all ages and both sexes, increases a new species for vegetable drinks, and meets various demands of people.

This document provides diuretic and natriuretic polypeptides. For example, this document provides polypeptides having diuretic and / or natriuretic activities. In some cases, a polypeptide provided herein can have diuretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing diuretic and / or natriuretic activities within a mammal.

A black tea fermentation process relates to a black tea fermentation method of black tea. The fresh tea leaves are fermented by stacking, greening, and kneading. The stacking fermentation is carried out in three stages: a. Low-temperature fermentation: the temperature is controlled at 28°C to 32°C, the humidity is controlled at 25% to 40%. 12-24 hours; b. High-temperature fermentation: temperature controlled at 40°C-50°C for fermentation, humidity controlled at 29-31%, and stacked for 6-12 hours; c. Medium-temperature fermentation: temperature controlled at about 35°C-38°C, The humidity is controlled at 28-36%, and the stack is piled up for 3-6 hours. It can activate various biological enzymes and fully convert them into tea polyphenols, cellulose, pectin and other components. It also has the effects of calming the nerves and nourishing the stomach, promoting digestion, regulating the stomach, enriching nutrition, improving immunity, and lowering blood fat.

Nutritionally strengthened honey improves its health care and therapeutic effects and pertinence, and uses it as a daily health food to overcome the shortcomings of existing honey in the treatment of existing superficial diseases and lack of prominent targets. It is composed of honey and one or several kinds of plant extracts that are recognized by the state as medicine and food. , choose the extracts of homologous plants of medicine and food as additive ingredients, carry out the effect targeting formed by scientific compatibility, cooperate with the original inherent effect of honey to strengthen the specific effect of honey, and obtain honey as the main ingredient, and the health care and treatment effects are significantly higher than Health food with honey. It is used to enhance immunity, improve sleep, promote lead discharge, clear throat, lose weight, remove chloasma, assist in lowering blood pressure, assist in lowering blood sugar, promote digestion, improve nutritional anemia, relieve visual fatigue, and assist in improving memory.

This invention relates to modified Vasoactive Intestinal Peptide (VIP) / Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor 2 (VPAC2) agonists (VPAC2 agonists) comprising a VPAC2 agonist linked to a polyethylene glycol polymer, as well as related formulations, dosages, and methods of administration thereof for therapeutic purposes. These VPAC2 agonists, compositions, and methods are useful in providing a treatment option for those individuals afflicted with a metabolic disorder such as diabetes, impaired glucose tolerance, metabolic syndrome, or prediabetic states, by inducing glucose-dependent insulin secretion in the absence of the therapeutically limiting side effect of reducing or lowering blood pressure.

The invention discloses lactobacillus plantarum and uses thereof, and particularly discloses lactobacillus plantarum and uses thereof in preparation of medicines or foods, the medicines, and the foods. The lactobacillus plantarum is deposited in the China Center for Type Culture Collection at Wuhan University in Wuhan, China, in September 6, 2013 with an accession number being CCTCC NO:M2013391 and an accession name being Lactobacillus plantarum Y-9. The lactobacillus plantarum has excellent probiotic functions, acid resistance and cholate resistance, can be stored for a long term, and can be used for effectively reducing cholesterol in blood, lowering blood pressure, boosting immunity, losing weight or adjusting intestinal flora.

The invention relates to a functional health care beverage and a preparation method and an application thereof, belonging to the technical field of health care beverages. The functional health care beverage is characterized in that the beverage comprises the following substances: 20-50% of Hibiscus manihot tender fruit, 5-20% of Chinese wolfberry fruit, 10-20% of Chinese yam, 5-10% of honey and the balance of purified water. The beverage provided by the invention has sufficient nutrition and high value of health care, contains a large amount of flavones, polysaccharides, chlorogenic acid, trace elements, amino acids and other functional factors, and belongs to pure natural green food beverages. Except for strong nutritional and health promotion effects, the beverage also has auxiliary therapeutic effects of resisting fatigue, enhancing endurance and immunity, nourishing and protecting liver, tonifying kidney, strengthening yang, resisting aging, scavenging free radicals, lowering blood pressure, reducing blood glucose, promoting digestion, strengthening stomach, moisturizing intestine and caring skin after long-term drinking.

The invention discloses dried jasmine flower and a preparing method thereof. The dried jasmine flower comprises the following raw materials by weight: 80-90 parts of soybean, 13-15 parts of jasmine flower, 3-5 parts of lily, 2-4 parts of common coltsfoot flower, 2-4 parts of gourd flower, 10-15 parts of maize, 3-4 parts of walnut, 4-6 parts of mulberry, 3-5 parts of thistle, 1-2 parts of sophora japonica twig, 2-4 parts of elm white bark, 4-6 parts of pollen typhae, 3-5 parts of dandelion, 2-4 parts of cucumber root, 1-2 parts of sweet tea root and 5-7 parts of sweet potato vine. The dried jasmine flower is rich in nutrients, delicate in taste and appropriate in saltiness and sweetness. Due to the addition of the jasmine flower to the raw materials, the dried jasmine flower has the functions of clearing liver fire, improving eyesight, promoting the secretion of saliva, slaking thirst, lowering blood pressure, strengthening the heart and resisting ageing, and assists a person in prolonging life, having longevity and keeping the body and the heart healthy. The preparing method is unique. Through the enzymolysis of the raw materials, the nutritional ingredients of the raw materials are more easily released and are more conveniently absorbed by a human body.

A new use of darusentan is provided in preparation of a pharmaceutical composition for lowering blood pressure in a patient exhibiting resistance to a baseline antihypertensive therapy with one or more drugs. The composition comprises darusentan in an amount providing a therapeutically effective daily dose; wherein (a) the composition is orally deliverable and / or (b) the daily dose of darusentan is effective to provide a reduction of at least about 3 mmHg in one or more blood pressure parameters selected from trough sitting systolic, trough sitting diastolic, 24-hour ambulatory systolic, 24-hour ambulatory diastolic, maximum diurnal systolic and maximum diurnal diastolic blood pressures. Further provided is a new use of darusentan in preparation of a pharmaceutical composition for lowering blood pressure in a patient exhibiting resistance to a baseline antihypertensive therapy, wherein the composition is administered adjunctively with at least one diuretic and at least one antihypertensive drug selected from ACE inhibitors, angiotensin II receptor blockers, beta-adrenergic receptor blockers and calcium channel blockers.

The present invention discloses the preparation process of mulberry stamen tea. The mulberry stamen tea is prepared with tender bud as the waste from mulberry garden management as main material and through deactivating enzyme, kneading, drying and other steps, and the drying step may be completed in different temperatures so as to form different types of mulberry stamen tea. The mulberry stamen tea is dark green, scented, sweet, mellow and nutritious, and has the health effects of diuresis, lowering blood pressure, reducing blood sugar, etc.

There is provided in accordance with an exemplary embodiment of the invention a method of treating diabetic patients comprising measuring a triglyceride level in a diabetic patient and applying a diabetes treatment according to the triglyceride level. Optionally, there is provided a method of screening. Alternatively or additionally, there is provided a method of weight loss. Alternatively or additionally, there is provided a method of relatively reducing HOMA-IR levels. Alternatively or additionally, there is provided a method of relatively reducing blood pressure. An exemplary device to apply the treatment is described.

The invention discloses an instant tea of eucommia male flower and a preparation method thereof, which uses eucommia male flower, eucommia leaf, hawthorn and puerarin as raw materials; the preparation method comprises the nine processing steps of cleaning and choosing, leaching, thermal treating, heat dissipating, extraction, filtrating, concentrating, granulating and bagging, etc. In the eucommia male flower instant tea of the invention, the eucommia male flower, the eucommia leaf, the hawthorn and the puerarin of the raw materials have the functions of lowering blood pressure, reducing blood, preventing cerebral thrombosis and myocardial infarction, preventing senile dementia, being antitumor and anti-aging, enhancing immunity, etc., with consistent efficacy direction, due to the efficacy combination of the four raw materials, the invention has compound synergism effect; besides, the promoting digestion and removing stagnated food, reinforcing spleen and strengthening stomach functions of hawthorn and improving cardiac function of puerarin and nourishing liver and kidney function of eucommia male flower and eucommia leaf can achieve complementary effect, which leads the health function of the tea to be more distinctive. Due to containing richly calcium, phosphorus, magnesium, potassium, etc., the invention is endowed with rich nutrition, faint scent and good taste.

The invention discloses cancer-preventing and anti-cancer health-care flour comprising blackberries, which is prepared from the following raw materials by weight in parts: 6-8 parts of blackberry, 40-50 parts of wheatmeal, 12-15 parts of maize, 8-10 parts of sword bean, 2-3 parts of sea cucmber, 3-4 parts of Lentinus edodes, 2-3 parts of tremella, 2-3 parts of black lycium chinense, 1-2 parts of purple cabbage, 1-2 parts of purslane, 2-3 parts of radix polygonati officinalis, 2-3 parts of rhizoma polygonati, 1-2 parts of folium ginseng, 1-2 parts of glossy privet fruit, 1-2 parts of poria cocos, 1-2 parts of moutan bark, 2-3 parts of gynostemma pentaphylla, 1-2 parts of pseudo-ginseng, 2-3 parts of green tea powder, and 1-2 parts of rhizoma curcumae longae. The flour prepared by the invention is unique in taste, processes a blackberry flavor, is rich in nutrition, is easy to digest, is suitable for processing various foods, and has the effects of preventing and curing cancer, regulating blood sugar level, lowering blood pressure, reducing blood fat, preventing arteriosclerosis, improving immunity, delaying senescence and maintaining beauty and keeping young after being eaten for a long time.

The invention discloses a lycium ruthenicum beverage and a preparation method thereof and provides a beverage prepared by taking dried lycium ruthenicum fruit powder as a main raw material and a preparation method thereof. The lycium ruthenicum beverage is composed of following raw materials by weight percent: 0.1%-7% of the dried lycium ruthenicum fruit powder, 0.05%-3% of guar gum, 0.2%-7% of CMC-Na (Carboxyl Methyl Cellulose-Na), 0.05%-3% of xanthan gum, 3%-15% of erythritol, 0.006%-0.6% of stevioside, 0.01%-0.8% of citric acid, 0.01%-0.4% of sodium citrate, 0.01%-1.5% of tea polyphenol and the balance being water. The beverage is prepared by taking the dried lycium ruthenicum fruit powder as the main raw material; reasonable compatibility and synergistic effects of all the components are utilized and the color of a product is amaranth; the lycium ruthenicum beverage has a unique flavor, no astringent and mellow mouth feel, and has the effects of nourishing liver and kidney, replenishing vital essence to improve eyesight and nourishing blood, enhancing the immunity of people, beautifying, resisting oxidization, decaying aging, resisting fatigues, lowering blood pressure and lowering blood sugar.